Search - tctmd.com

Displaying 1 - 20 of 265

Sort: Relevancy | Date

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood

December 23, 2020

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Industry News

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

December 16, 2020

News Daily News

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

Todd Neale

December 16, 2020

News Daily News

Review Spotlights SCAD Diagnosis and Treatment

L.A. McKeown

December 15, 2020

News Daily News

Knowing Comorbidities, Medication Use May Save Lives in COVID-19

Michael O'Riordan

December 15, 2020

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Todd Neale

December 14, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Daily News

CAC Testing Improves Pretest Probability of Obstructive CAD

Michael O'Riordan

November 23, 2020

Advertisement

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Funding the Future: How Industry Support for CV Trials Could Evolve

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

Review Spotlights SCAD Diagnosis and Treatment

Knowing Comorbidities, Medication Use May Save Lives in COVID-19

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Inclisiran Approved in Europe for Lowering LDL Cholesterol

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Even Low-Dose Steroids Increase the Risk of CVD

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

More Women Than Men Develop HF or Die After STEMI

Colchicine in the Crosshairs for Its High US Cost

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

CAC Testing Improves Pretest Probability of Obstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content